Skip to main content
Clinical Trials/NCT01614067
NCT01614067
Terminated
Phase 4

Delayed Start to Ovarian Stimulation Improves Oocyte Maturation and Quality: A Randomized Trial

University of California, San Francisco1 site in 1 country30 target enrollmentMay 2012

Overview

Phase
Phase 4
Intervention
Ganirelix acetate
Conditions
Diminished Ovarian Reserve
Sponsor
University of California, San Francisco
Enrollment
30
Locations
1
Primary Endpoint
Fertilization Proportions
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

In couples with infertility secondary to Diminished Ovarian Reserve, the investigators hypothesize that a delayed start (7 day) to ovarian stimulation with an GnRH antagonist (Ganirelix) will improve oocyte maturation and quality, and improve pregnancy outcomes.

Detailed Description

Over the past two decades, the success rate of assisted reproductive technology (ART) has dramatically increased. This increase is attributed to improvements in embryo culture, laboratory conditions, and optimization of ovarian stimulation protocols. Over the past years, there has been more interest in altering the ovarian stimulation protocol to improve outcomes. For example, recently our group found that a modification of ovulation trigger toward a more physiologic process improves oocyte quality and pregnancy outcomes. Others have suggested minimal stimulation improves in vitro fertilization (IVF) outcomes. The investigators propose to further investigate modifying the ovarian stimulation for women who have "decreased" ovarian reserve. The investigators propose that a delayed start to ovarian stimulation will improve oocyte maturation and quality and pregnancy outcomes. No published studies to date have evaluated if a delayed start to ovarian stimulation improves pregnancy outcomes. However, the investigators hypothesize that the use an antagonist for a delayed start of stimulation will work by one of two mechanisms: I. The partial suppression of FSH will allow for further recruitment of early antral follicles. II. The partial suppression of FSH will allow for further FSH responsiveness in existing follicles to synchronize the primary cohort, thereby increasing the total number of follicles.

Registry
clinicaltrials.gov
Start Date
May 2012
End Date
September 2014
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Antral Follicle Count (AFC) less than or equal to 4 as measured by transvaginal ultrasound (TVUS), or
  • Cancellation of a prior IVF cycle due to poor ovarian response.
  • Patients will receive an antagonist stimulation protocol for IVF, or IVF with Intracytoplasmic Sperm Injection (ICSI).

Exclusion Criteria

  • Severe male factor infertility requiring surgical intervention to obtain sperm
  • Major uterine abnormality,
  • Preimplantation genetic diagnostic (PGD) testing,
  • Planned cycles without embryo transfer (for example, freeze-all, donor, or surrogate cycles).

Arms & Interventions

Delayed Start

Study subjects will receive 7 days of pre-treatment with a GnRH antagonist (Delayed Start) before standard ovarian stimulation with FSH/LH.

Intervention: Ganirelix acetate

Conventional Start

Ovarian stimulation with standard antagonist protocols (no delay).

Intervention: Ganirelix acetate

Outcomes

Primary Outcomes

Fertilization Proportions

Time Frame: 8 to 24 hours after in vitro fertilization, oocytes will be checked for fertilization

Developmental competence (fertilization of oocytes) through standard in vitro fertilization (estimated time frame to be between 8-24 hours following IVF). This percentage will be calculated as the number of fertilized eggs ( 2PN stage) per total number of eggs collected from the egg retrieval.

Number of Oocytes Retrieved

Time Frame: up to 1 hour after oocytes retrieved

The egg retrieval procedure will be performed 36 hours after the ovulation trigger. The procedure is estimated to take up to 1 hour at study visit as part of routine care. The number of retrieved eggs will be counted

Secondary Outcomes

  • Pregnancy Rates(2 to 3 weeks following embryo transfer)
  • Stages of Oocyte Nuclear Maturation(average of 1 to 2 hours on the Day of Retrieval)
  • Number of Mature Follicles(up to 1 hour (during the Transvaginal Ultrasound before Retrieval of Oocytes))
  • Oocyte Recovery Rate(up to 1 hours after oocyte retrieval)
  • Embryo Quality(One hour on day 2 or 3 (following IVF procedure))

Study Sites (1)

Loading locations...

Similar Trials